The capsid antigen of Epstein-Barr virus in nasopharyngeal carcinomas: Comparison of serum antibody titre, cellular antigen content and histopathology
β Scribed by N. Falser
- Book ID
- 112311246
- Publisher
- Springer-Verlag
- Year
- 1984
- Tongue
- English
- Weight
- 716 KB
- Volume
- 239
- Category
- Article
- ISSN
- 0302-9530
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND Serologic measurement of antibodies to EpsteinβBarr virus (EBV) immunoglobulin A/viral capsid antigen (IgA/VCA) and early antigen (IgA/EA) has been used widely to screen for nasopharyngeal carcinoma (NPC) in China. Recently, it was found that plasma EBV DNA concentration
The feasibility of using elevated Epstein-Barr virus (EBV) specific-IgG antiviral capsid antigen (VCA) and IgA anti-VCA antibody levels as an aid in diagnosis of nasopharyngeal carcinoma (NPC) was analyzed by determination of serum antibody titers to EBV in 54 NPC patients, 114 healthy blood donors,